Incidence of the mucopolysaccharidoses in Northern Ireland

@article{Nelson1997IncidenceOT,
  title={Incidence of the mucopolysaccharidoses in Northern Ireland},
  author={John Nelson},
  journal={Human Genetics},
  year={1997},
  volume={101},
  pages={355-358}
}
  • J. Nelson
  • Published 1 December 1997
  • Biology, Medicine
  • Human Genetics
Abstract An epidemiological study of the mucopolysaccharidoses (MPS) in Northern Ireland using multiple ascertainment sources was carried out and the incidence rate for the period 1958–1985 was estimated. An incidence of approximately 1 in 76 000 live births was obtained for MPS 1H (Hurler phenotype); 1 in 280 000 for MPS 1 H/S (Hurler/Scheie phenotype); 1 in 140 000 live births (1 in 72 000 male live births) for MPS II (Hunter syndrome); 1 in 280 000 for MPS III (Sanfilippo syndrome) and 1 in… Expand
Incidence of the mucopolysaccharidoses in Western Australia
An epidemiological study of the mucopolysaccharidoses in Western Australia (WA) using multiple ascertainment sources was carried out and the incidence rate for the period 1969–1996 was estimated. AnExpand
Cumulative incidence rates of the mucopolysaccharidoses in Germany
TLDR
The cumulative incidence pattern of MPS in Germany was compared with the corresponding rates among other industrial nations obtained from recent literature: the crude cumulative rates for all types of mucopolysaccharidoses were similar among all published populations; however, different frequencies of the various forms of M PS were observed. Expand
Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004
TLDR
Overall incidence of MPS in Taiwan was consistent with that reported in Western populations, however, in contrast to the higher incidence ofMPS I in mostWestern populations, this study showed a higher incidenceof MPS II in Taiwan. Expand
Estimated birth prevalence of mucopolysaccharidoses in Brazil
TLDR
The birth prevalence of MPS in total and of each MPS type, in Brazil is estimated, based on the frequency of the commonest IDUA pathogenic variant and in the records of two large patient databases. Expand
The live-birth prevalence of mucopolysaccharidoses in Estonia.
TLDR
A retrospective epidemiological study of MPSs in Estonia found the live-birth prevalence for all MPS subtypes was found to be 4.05 per 100,000 live births, which is consistent with most other European studies. Expand
Epidemiology of mucopolysaccharidoses.
TLDR
Overall, the frequency of MPS varies for each population due to differences in ethnic backgrounds and/or founder effects that affect the birth prevalence of each type of M PS, as seen for other rare genetic diseases. Expand
Prevalence rates of mucopolysaccharidoses in Poland
TLDR
The prevalence pattern of mucopolysaccharidosis in Poland is lower when compared to the prevalence reported for other European countries, such as the Netherlands, Czech Republic, or Germany, but similar to countries like Sweden and Denmark. Expand
Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities
TLDR
Due to the large US population and state fragmentation, US incidence and prevalence were found to be lower than other countries, Nonetheless, state-level studies in the US supported these figures. Expand
Clinical and laboratorial study of 19 cases of mucopolysaccharidoses.
TLDR
The high relative frequency of Maroteaux-Lamy disease contrasts with most reports in the literature and could express a population variability. Expand
Hunter syndrome (Muccopolysaccharridosis Type II) in Macedonia and Bulgaria.
TLDR
Calculated incidence and prevalence rates in two South Eastern European countries, and 2 novel genetic alterations correlated with their phenotypes are reported, indicating that Correlating phenotype and genotype remains a complex endeavour. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 15 REFERENCES
Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype
TLDR
The distribution and relative frequencies of the I113F and T312S mutations in Australia corresponded to those observed in Northern Ireland and are unique to these two populations, suggesting that both mutations were probably introduced to Australia by Irish migrants during the 19th century. Expand
Dental findings in mucopolysaccharidosis type IV A (Morquio's disease type A).
TLDR
Dental changes seen in MPS IV A (N-acetylgalactosamine-6-sulphate sulphatase deficiency) can aid in the diagnosis of patients affected by MPSIV A and are especially useful in mild atypical cases. Expand
Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.
TLDR
The identification of four previously undescribed mutations for MPS-I begins to document the expected genetic heterogeneity in Mps-I and provides the first molecular explanations for the broad range of clinical phenotypes observed. Expand
Cardiovascular studies in the mucopolysaccharidoses.
TLDR
The main echocardiographical findings were thickening of the interventricular septum and left ventricular posterior wall in the absence of ECG evidence of ventricular hypertrophy, which suggest an infiltrative cardiomyopathy owing to mucopolysaccharide deposition as a cause of the cardiac thickening rather than true ventricularhypertrophy. Expand
Foamy changes of placental cells in probable beta glucuronidase deficiency associated with hydrops fetalis.
TLDR
Mucopolysaccharidosis type VII (MPS VII, beta glucuronidase deficiency) has been described in association with non-immune hydrops fetalis, with the main clue to the diagnosis coming from the presence of pronounced foamy cytoplasmic change in the villous Hofbauer cells of the placenta. Expand
Prenatal diagnosis of mucopolysaccharidosis by two‐dimensional electrophoresis of amniotic fluid glycosaminoglycans
TLDR
Amniotic fluid from 72 pregnancies at risk for mucopolysaccharidosis have been analysed for glycosaminoglycans (GAG) by means of two‐dimensional electrophoresis and it is found completely reliable for prenatal diagnosis. Expand
Distinction Among Four Forms of Hurler's Syndrome.∗ †
  • K. Terry, A. Linker
  • Chemistry, Medicine
  • Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1964
TLDR
Analysis of the urinary AMPS from individuals with Hurler's syndrome indicates there are 4 forms that can be distinguished by their excretion pattern, and an atypical “adult form” (autosomal recessive) was shown to excrete chondroitin sulfate B and heparitin sulfates in excess. Expand
Pituitary function studies in a case of mild Hunter's syndrome (MPS IIB).
TLDR
The results indicated that anterior pituitary function and, in particular, growth hormone secretion was normal and the most likely explanation for the short stature is an osseous growth plate disturbance with infiltration of the epiphyses by mucopolysaccharides. Expand
Clinical findings in 12 patients with MPS IV A (Morquio's disease)
Typical dental changes were present in all cases, although they were of variable degree. However, the tooth morphology would appear to be highly specific for MPS IV A, and is not found in MPS IV BExpand
Allelism, non-allelism, and genetic compounds among the mucopolysaccharidoses.
TLDR
It is proposed that the genes for the strikingly dissimilar Hurler and Scheie syndromes are allelic, and that genetic compounds of the Hurlerand Scheie genes occur, presenting an intermediate phenotype. Expand
...
1
2
...